🇺🇸 FDA
Patent

US 11246858

Immunoresponsive methods of treating tumors

granted A61KA61K31/4422A61K39/3955

Quick answer

US patent 11246858 (Immunoresponsive methods of treating tumors) held by INSTITUT PASTEUR DE MONTEVIDEO expires Mon Feb 10 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
INSTITUT PASTEUR DE MONTEVIDEO
Grant date
Tue Feb 15 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 10 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
15
CPC classes
A61K, A61K31/4422, A61K39/3955, A61P, A61P35/00